The effect of ondansetron on pyridostigmine-induced blood acetylcholinesterase inhibition in the guinea pig

Drug and Chemical Toxicology

Volumn 19, Issue 1-2, 1996, Pages 1-19

  Capacio, B R ^a   Byers, C E ^a   Anderson, D R ^a   Matthews, R L ^a   Brown, D E ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; ONDANSETRON; ORGANOPHOSPHORUS COMPOUND; PYRIDOSTIGMINE; SEROTONIN 3 ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; GUINEA PIG; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0029938482     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.3109/01480549609002193     Document Type: Article

References (29)

1. Fozard, J.R., 5-HT; The Enigma Variations, TIPS., 8, 501-506 (December 1987).
2. 3H]BRL 43694, binds to presynaptic sites in the nucleus tractus solitarius of the rat, Neuropharmacol., 28, 1367-1376, (1989).
3. Watling, K.J., 5-HT3 Receptor Agonists and Antagonists, in "Neurotransmissions", Research Biochemicals Inc., Nantick, 5, 1-5, (1989).
4. Bermudez, J., Boyle, E.A., Miner, W.D., Sanger, G.J., The Anti-Emetic potential of the 5-hydroxytryptamine 3 receptor antagonist BRL 43694, Br. J. Cancer., 58, 644-650, (1988).
5. 3 -receptor antagonist, GR38032F, Cancer Treat. Rev., 14, 333-336, (1987).
6. Butler, A., Hill, J.M., Ireland, S.J., Jordan, C.C., Tyers, M.B., Pharmacologic properties of GR38032F, a novel antagonist at 5-HT receptors, Br. J. Pharmacol., 94, 397-412, (1988).
7. Chaffee, B.J., Tankanow, R.M., Ondansetron-the first of a new class of antiemetic agents. Clin. Pharm., 10, 430-446, (1991).
8. Priestman, T.J., Upadhyaya, B.K., Palmer, J.L., The pharmacokinetics of ondansetron (OD) in the elderly, Proc. Annu. Meet. Am. Soc. Clin. Oncol., 9, A306, (1990).
9. 3-receptor antagonist, Br. J. Pharmacol., 93, 985-993, (1988).
10. Costall, B., Domeney A.M., Naylor R.J., Tattersall., 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-Induced emesis, Neuropharmacol., 25, 959-961, 1986.
11. Keeler, J.R., Hurst, C.G., Dunn, M.A., Pyridostigmine used as a nerve agent pretreatment under wartime conditions, JAMA., 266, 693-695, (1991).
12. Berry, W.K., Davies, D.R., The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate, Biochem. Pharmacol., 19, 927-934, (1970).
13. Siakotos, A.N., Filbert, M., Hester, R., A specific radioisotopic assay for acetylcholinesterase and pseudocholinesterase in brain and plasma, Biochem. Med., 3, 1-12, (1969).
14. Harris, L.W., Anderson D.R., Lennox, W.J., Woodard, C.L., Pastelak, A.M., Vanderpool, B.A., Evaluation of several oximes as reactivators of unaged soman-inhibited whole blood acetylcholinesterase in rabbits, Biochem. Pharmacol. 40, 2677-2682, (1990).
15. Lennox, W.J., Harris, L.W., Talbot, B.G., Anderson, D.R., Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality, Life Sci., 37, 793-798, (1985).
16. Anderson, D.R., Harris, L.W., Lennox, W.J., Solana, R.P., Effects of subacute pretreatment with carbamate together with acute adjunct pretreatment against nerve agent exposure, Drug Chem., Toxicol., 14, 1-19, (1991).
17. 3 receptor antagonist ondansetron, FASEB J., 7(4), A699, (1993).
18. 3 receptors, in "Neuronal Serotonin", N.N. Osborne, and M. Hamon, eds., Wiley, 1988, p. 465-506.
19. 3 receptors, Trends Neurosci., 9, 424-428, (1986).
20. Buchheit, K.H., Engel, G., Mutschler, E., Richardson, B., Study of the contractile effect of 5-hydroxytyptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Evidence for two distinct release mechanisms, Naunyn-Schmiedeberg's Arch. Pharmacol., 329, 36-41, (1985).
21. Buchheit, K.H., Costall, B., Engel, G., Gunning, S.J., Naylor, R.J., Richardson, B.P., 5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205-930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in-vivo, J. Pharm. Pharmacol, 37, 664-667, (1985).
22. Costall, B., Gunning, S.J., Naylor, R.J., Tyers, M.B., The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig, Br. J. Pharmacol., 91., 263-264, (1987).
23. Gershon, M.D., Wade, P.R., Kirchgessner, A.L., Tamir, H., 5-HT receptor subtypes outside the central nervous system. Roles in the physiology of the gut, Neuropsychopharmacology, 3, 385-395, (1990).
24. 3 receptor antagonists, a new approach in emesis: A review of ondansetron, granisetron and tropisetron, Anti-Cancer Drugs, 2, 343-355, (1991).
25. Talley, N.J., 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: Clinical implications, Alimentary Pharmacology and Therapeutics, 6, 273-289, (1992).
26. Buchheit, K.H., Gamse, R., Bertholet, A., Buscher, H.H., Antagonists at serotoninergic 5-HT3 receptors increase gastric emptying of solids and liquids in the rat, Gastroenterology, 96, A63, (1989).
27. Somani, S.M., Roberts, J.B., Wilson, A., Pyridostigmine metabolism in man. Clin. Pharmacol. Ther., 13, 393-399, (1972).
28. 14C-pyridostigmine, Experientia, 15, 527, (1974).
29. Saynor, D.A., Dixon, C.M., The Metabolism of Ondansetron, Eur. J. Clin. Oncol., 25, S75-S77, (1989).